Get the Stockscreener App
3.83
0.26%
-0.010
After Hours:
3.83
Polypid Ltd stock is traded at $3.83, with a volume of 61,939.
It is down -0.26% in the last 24 hours and up +14.84% over the past month.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
See More
Previous Close:
$3.84
Open:
$3.8
24h Volume:
61,939
Relative Volume:
0.86
Market Cap:
$60.89M
Revenue:
-
Net Income/Loss:
$-23.87M
P/E Ratio:
-0.1947
EPS:
-19.67
Net Cash Flow:
$-47.63M
1W Performance:
+11.34%
1M Performance:
+14.84%
6M Performance:
+34.39%
1Y Performance:
+19.69%
1-Day Range:
$3.59
$3.88
1-Week Range:
$3.4021
$3.88
52-Week Range:
$2.30
$3.93
Polypid Ltd Stock (PYPD) Company Profile
Compare PYPD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.83 | 61.05M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Initiated | Roth Capital | Buy |
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Sep-14-21 | Initiated | JMP Securities | Mkt Outperform |
| Jul-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-10-20 | Initiated | Alliance Global Partners | Buy |
| Jul-21-20 | Initiated | BMO Capital Markets | Outperform |
| Jul-21-20 | Initiated | Barclays | Overweight |
| Jul-21-20 | Initiated | Raymond James | Outperform |
View All
Polypid Ltd Stock (PYPD) Latest News
Using flow based indicators on PolyPid Ltd.July 2025 WrapUp & AI Enhanced Trading Signals - newser.com
Is PolyPid Ltd. stock a contrarian buyWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Why PolyPid Ltd. stock could benefit from AI revolutionProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com
Why PolyPid Ltd. stock could rally in 2025Earnings Beat & High Accuracy Swing Trade Signals - newser.com
PolyPid Ltd. (NASDAQ:PYPD) Sees Significant Increase in Short Interest - MarketBeat
How to build a custom watchlist for PolyPid Ltd.Trade Volume Summary & High Conviction Buy Zone Alerts - newser.com
Is PolyPid Ltd. stock reversal real or fakeMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Is PolyPid Ltd. stock undervalued vs historical averagesIPO Watch & Short-Term Swing Trade Alerts - newser.com
Using data tools to time your PolyPid Ltd. exit2025 Winners & Losers & Long-Term Growth Plans - newser.com
Published on: 2025-10-30 23:33:37 - newser.com
Will PolyPid Ltd. stock outperform growth indexesAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com
What makes PolyPid Ltd. stock attractive to growth fundsInflation Watch & Weekly Top Stock Performers List - newser.com
Predicting PolyPid Ltd. trend using moving averages2025 Market Overview & Accurate Buy Signal Alerts - newser.com
PolyPid (NASDAQ: PYPD) to report third-quarter results Nov. 12; 8:30 a.m. ET - Stock Titan
How PolyPid Ltd. stock reacts to global recession fearsTrade Performance Summary & Long-Term Safe Investment Plans - fcp.pa.gov.br
International - FinancialContent
Is PolyPid (NASDAQ:PYPD) A Risky Investment? - simplywall.st
Why PolyPid Ltd. stock remains resilientEarnings Summary Report & AI Enhanced Trading Signals - fcp.pa.gov.br
Will PolyPid Ltd. stock reach all time highs in 2025July 2025 Sentiment & Fast Entry High Yield Stock Tips - fcp.pa.gov.br
S P Trends: Will PolyPid Ltd. stock outperform growth indexesInflation Watch & Technical Pattern Recognition Alerts - Fundação Cultural do Pará
Polypid Ltd Stock (PYPD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):